Your browser doesn't support javascript.
loading
A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Herbst, Roy S; Hammond, Lisa A; Carbone, David P; Tran, Hai T; Holroyd, Kenneth J; Desai, Avinash; Williams, Jon I; Bekele, B Nebiyou; Hait, Howard; Allgood, Victoria; Solomon, Stephen; Schiller, Joan H.
Affiliation
  • Herbst RS; Department of Thoracic/Head and Neck Medical Oncology and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Clin Cancer Res ; 9(11): 4108-15, 2003 Sep 15.
Article in En | MEDLINE | ID: mdl-14519633
Subject(s)
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Cholestanols / Carcinoma, Non-Small-Cell Lung / Angiogenesis Inhibitors / Lactates / Lung Neoplasms Type of study: Guideline / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2003 Type: Article Affiliation country: United States
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Cholestanols / Carcinoma, Non-Small-Cell Lung / Angiogenesis Inhibitors / Lactates / Lung Neoplasms Type of study: Guideline / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2003 Type: Article Affiliation country: United States